| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56127SS | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX0010A488-100 | |||
| Alexa Fluor 546 | DDX0010A546-100 | |||
| Alexa Fluor 647 | DDX0010A647-100 | |||
| Biotin | DDX0010B-100 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18056SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64946-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77275-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43298-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72107 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71006 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22436-100ug | |||
![Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody [NB100-56127] - FFPE tissue section of human tonsil stained for CD40 expression using this antibody at 1:2000. Staining is seen in the dendritic cells. Hematoxylin-eosin counterstain.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-Immunohistochemistry-Paraffin-NB100-56127-img0003.jpg "Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody [NB100-56127] - FFPE tissue section of human tonsil stained for CD40 expression using this antibody at 1:2000. Staining is seen in the dendritic cells. Hematoxylin-eosin counterstain.")
![Immunohistochemistry: CLEC10A/CD301 Antibody (125A10.03) [DDX0010P-100] - IHC staining of lungcryosectionwith 125A10.03](http://images.novusbio.com/fullsize/CLEC10A-CD301-Antibody-125A10-03-Immunohistochemistry-DDX0010P-100-img0009.jpg "Immunohistochemistry: CLEC10A/CD301 Antibody (125A10.03) [DDX0010P-100] - IHC staining of lungcryosectionwith 125A10.03")
![Flow Cytometry: CLEC10A/CD301 Antibody (125A10.03) [DDX0010P-100] - FACS analysisof monocyte-derivedDCs (GM+IL4) stained with125A10.03+ goat anti-mouse FITC](http://images.novusbio.com/fullsize/CLEC10A-CD301-Antibody-125A10-03-Flow-Cytometry-DDX0010P-100-img0010.jpg)
![Western Blot: RALBP1 Antibody (2A1) [H00010928-M02] - RALBP1 monoclonal antibody (M02), clone 2A1 Analysis of RALBP1 expression in HeLa.](http://images.novusbio.com/fullsize/RALBP1-Antibody-2A1-Western-Blot-H00010928-M02-img0006.jpg "Western Blot: RALBP1 Antibody (2A1) [H00010928-M02] - RALBP1 monoclonal antibody (M02), clone 2A1 Analysis of RALBP1 expression in HeLa.")
![Western Blot: RALBP1 Antibody (2A1) [H00010928-M02] - Analysis of RALBP1 transfected lysate using anti-RALBP1 monoclonal antibody and Protein A Magnetic Bead, and immunoblotted with RALBP1 MaxPab rabbit polyclonal antibody.](http://images.novusbio.com/fullsize/RALBP1-Antibody-2A1-Western-Blot-H00010928-M02-img0004.jpg)
![Western Blot: RALBP1 Antibody (2A1) [H00010928-M02] - RALBP1 monoclonal antibody (M02), clone 2A1. Analysis of RALBP1 expression in C32.](http://images.novusbio.com/fullsize/RALBP1-Antibody-2A1-Western-Blot-H00010928-M02-img0007.jpg)
![ELISA: RALBP1 Antibody (2A1) [H00010928-M02] - Detection limit for recombinant GST tagged RALBP1 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/RALBP1-Antibody-2A1-ELISA-H00010928-M02-img0008.jpg)
![Western Blot: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF by WB of HEK293T, MCF-7, Hep-G2, A-549, SW620, SK-MEL-28 (SK), Jurkat, TCMK-1, and NIH 3T3 lysate. Antibody: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420) Secondary: HRP-conjugated goat anti-rabbit IgG.](http://images.novusbio.com/fullsize/CTCF-Antibody-BLR041F-Western-Blot-NBP2-76420-img0001.jpg "Western Blot: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF by WB of HEK293T, MCF-7, Hep-G2, A-549, SW620, SK-MEL-28 (SK), Jurkat, TCMK-1, and NIH 3T3 lysate. Antibody: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420) Secondary: HRP-conjugated goat anti-rabbit IgG.")
![Simple Western: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of mouse CTCF by Simple Western™. Samples: Whole cell lysate (2.0 mg/mL) from NIH 3T3 cells prepared using NETN lysis buffer. Antibody: Rabbit anti-CTCF recombinant monoclonal antibody [BLR041F] (NBP2-76420) used at 1:10, 1:50, and 1:250. Separation and Detection: SallySue ProteinSimple instrument with the 12-230 kDa separation module and anti-Rabbit detection module. Left Panel: Virtual Lane View. Right Panel: Electropherogram. Image validated internally.](http://images.novusbio.com/fullsize/nbp2-76420_rabbit-monoclonal-ctcf-antibody-blr041f-simple-western-303202311310.jpg)
![Simple Western: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF by Simple Western™. Samples: Whole cell lysate (0.08 mg/mL) from HEK293T cells prepared using NETN lysis buffer. Antibody: Rabbit anti-CTCF recombinant monoclonal antibody [BLR041F] (NBP2-76420) used at 1:10, 1:50, and 1:250. Separation and Detection: SallySue ProteinSimple instrument with the 12-230 kDa separation module and anti-Rabbit detection module. Left Panel: Virtual Lane View. Right Panel: Electropherogram. Image validated internally.](http://images.novusbio.com/fullsize/nbp2-76420_rabbit-monoclonal-ctcf-antibody-blr041f-simple-western-303202311923.jpg)
![Immunocytochemistry: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF in FFPE MCF-7 cells by ICC. Antibody: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CTCF-Antibody-BLR041F-Immunocytochemistry-NBP2-76420-img0003.jpg)
![Immunohistochemistry: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of mouse CTCF in FFPE renal cell carcinoma by IHC. Antibody: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CTCF-Antibody-BLR041F-Immunohistochemistry-NBP2-76420-img0004.jpg)
![Immunohistochemistry: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF in FFPE lung carcinoma by IHC. Antibody: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CTCF-Antibody-BLR041F-Immunohistochemistry-NBP2-76420-img0002.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: CTCF Antibody (BLR041F) [NBP2-76420] - Detection of human CTCF by WB of immunoprecipitates from HEK293T lysate. Antibodies: Rabbit anti-CTCF recombinant monoclonal [BLR041F] (NBP2-76420) and rabbit anti-CTCF (NB500-177).](http://images.novusbio.com/fullsize/CTCF-Antibody-BLR041F-Immunoprecipitation-NBP2-76420-img0005.jpg)
![Flow Cytometry-CTCF Antibody (BLR041F) [NBP2-76420] -Rabbit anti-CTCF recombinant monoclonal antibody [BLR041F] or isotype control (unshaded). Secondary: DyLight® 650-conjugatedgoat anti-rabbit IgG.](http://images.novusbio.com/fullsize/nbp2-76420_rabbit-monoclonal-ctcf-antibody-blr041f-flow-cytometry-287202312246..jpg)
![Western Blot: Complement Component C1qA Antibody [NBP3-13331] - Rat plasma (30 ug) was separated by 12% SDS-PAGE, and the membrane was blotted with Complement Component C1qA antibody (NBP3-13331) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-Western-Blot-NBP3-13331-img0005.jpg "Western Blot: Complement Component C1qA Antibody [NBP3-13331] - Rat plasma (30 ug) was separated by 12% SDS-PAGE, and the membrane was blotted with Complement Component C1qA antibody (NBP3-13331) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: Complement Component C1qA Antibody [NBP3-13331] - Rat thymus gland. Complement Component C1qA stained by Complement Component C1qA antibody (NBP3-13331) diluted at 1:2000. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-Immunohistochemistry-Paraffin-NBP3-13331-img0002.jpg)
![Western Blot: Complement Component C1qA Antibody [NBP3-13331] - Mouse plasma (50 ug) was separated by 12% SDS-PAGE, and the membrane was blotted with Complement Component C1qA antibody (NBP3-13331) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-Western-Blot-NBP3-13331-img0001.jpg)
![Western Blot: Complement Component C1qA Antibody [NBP3-13331] - Human plasma (30 ug) was separated by 12% SDS-PAGE, and the membrane was blotted with Complement Component C1qA antibody (NBP3-13331) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-Western-Blot-NBP3-13331-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: DHX37 Antibody [NBP3-18056] - Rat FR cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with DHX37 Antibody (NBP3-18056) at 1ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/DHX37-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-18056-img0005.jpg "Immunocytochemistry/Immunofluorescence: DHX37 Antibody [NBP3-18056] - Rat FR cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with DHX37 Antibody (NBP3-18056) at 1ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.")
![Immunohistochemistry-Paraffin: DHX37 Antibody [NBP3-18056] - Analysis of a FFPE tissue section of mouse colon using 1:200 dilution of DHX37 (NBP3-18056) antibody. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/DHX37-Antibody-Immunohistochemistry-Paraffin-NBP3-18056-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: DHX37 Antibody [NBP3-18056] - Caco-2 cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with DHX37 Antibody (NBP3-18056) at 2ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/DHX37-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-18056-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: DHX37 Antibody [NBP3-18056] - NIH3T3 cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with DHX37 Antibody (NBP3-18056) at 2ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/DHX37-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-18056-img0004.jpg)
![Immunohistochemistry-Paraffin: DHX37 Antibody [NBP3-18056] - Analysis of a FFPE tissue section of human colon using 1:200 dilution of DHX37 (NBP3-18056) antibody. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/DHX37-Antibody-Immunohistochemistry-Paraffin-NBP3-18056-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0022.jpg "Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.")
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Benard A, Sala C, Pluschke G (2016)Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.PLoS ONE 11(11): e0167059](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0026.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with RPE conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0012.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Dong M, Zhong L, Chen WQ, Ji XP, Zhang M, Zhao YX, et al. (2012) Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits.PLoS ONE 7(6): e39695.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0014.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Marie-Claude Bourdillon, Jacques Randon, Lydie Barek, et al.,](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0006.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Ruschke K, Ebelt H, Kloting N, Boettger T, Raum K, Bluher M, et al. (2009) Defective Peripheral Nerve Development Is Linked to Abnormal Architecture and Metabolic Activity of Adipose Tissue in Nscl-2 Mutant Mice.PLoS ONE 4(5): e5516.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0009.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Seno T, Hamaguchi M, Ashihara E, Kohno M, Ishino H, Yamamoto A, et al. (2011) 15-Deoxy-delta 12,14 Prostaglandin J2 Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice. PLoS ONE 6(10): e25541.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0013.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Zhao X, Dimayuga PC, Zhou J, Li X, Yano J, et al. (2012) CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide.PLoS ONE 7(2): e30780.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0015.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang B, Dai S, Dong Z, Sun Y, Song X, Guo C, et al. (2014) The Modulation of Endoplasmic Reticulum Stress by Chemical Chaperone Upregulates Immune Negative Cytokine IL-35 in Apolipoprotein E-Deficient Mice.PLoS ONE 9(1): e87787.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0016.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Liu XL, Zhang PF, Ding SF, Wang Y, Zhang M, Zhao YX, et al. (2012) Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice.PLoS ONE 7(3): e33497.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0017.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Lio WM, Dimayuga PC, Zhou J, Zhao X, Yano J, et al. (2014) Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro. PLoS ONE 9(3): e92095.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0018.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Kennedy A, Gruen ML, Gutierrez DA, Surmi BK, Orr JS, Webb CD, et al. (2012) Impact of Macrophage Inflammatory Protein-1a Deficiency on Atherosclerotic Lesion Formation, Hepatic Steatosis, and Adipose Tissue Expansion.PLoS ONE 7(2): e31508.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0020.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang L, Yang M, Arias A, Song L, Li F, Tian F, et al. (2015) Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis. PLoS ONE 10(6): e0125961.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0021.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Niven J, Hoare J, McGowan D, Devarajan G, Itohara S, Gannage M, et al. (2015) S100B Up-Regulates Macrophage Production of IL1b and CCL22 and Influences Severity of Retinal Inflammation.PLoS ONE 10(7): e0132688.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0024.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Shuto Y, Asai A, Nagao M, Sugihara H, Oikawa S (2015) Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.PLoS ONE 10(8): e0136840.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0025.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with FITC conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0001.jpg)
![Western Blot: MAVS Antibody [NBP1-77275] - A20 cell lysate with MAVS antibody at (A) 0.5, (B) 1 and (C) 2 ug/ml.](http://images.novusbio.com/fullsize/MAVS-Antibody-Western-Blot-NBP1-77275-img0001.jpg "Western Blot: MAVS Antibody [NBP1-77275] - A20 cell lysate with MAVS antibody at (A) 0.5, (B) 1 and (C) 2 ug/ml.")
![Immunohistochemistry-Paraffin: MAVS Antibody [NBP1-77275] - Human brain tissue with MAVS antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/MAVS-Antibody-Immunohistochemistry-Paraffin-NBP1-77275-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: MAVS Antibody - BSA Free [NBP1-77275] - Immunofluorescence of MAVS in Human Brain cells with MAVS antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77275_rabbit-polyclonal-mavs-antibody-2711202420432381.jpg)
![Western Blot: T-bet/TBX21 Antibody (4B10) [NBP1-43298] - CD4+ T cells were sorted from mouse spleen, activated with Anti-Mouse CD3 and Anti-Mouse CD28, followed by culture in Th1-polarizing conditions, and re-activation with PMA and Ionomycin. Lysates from control (left) or PMA and Ionomycin-re-activated (right](http://images.novusbio.com/fullsize/T-bet-TBX21-Antibody-4B10-Western-Blot-NBP1-43298-img0002.jpg "Western Blot: T-bet/TBX21 Antibody (4B10) [NBP1-43298] - CD4+ T cells were sorted from mouse spleen, activated with Anti-Mouse CD3 and Anti-Mouse CD28, followed by culture in Th1-polarizing conditions, and re-activation with PMA and Ionomycin. Lysates from control (left) or PMA and Ionomycin-re-activated (right")
![Flow (Intracellular): T-bet/TBX21 Antibody (4B10) [NBP1-43298] - Intracellular staining of normal human peripheral blood cells with Anti-Human CD8a APC and 0.125 ug of Anti-Human/Mouse T-bet PerCP-Cy5.5 using the Foxp3 Fixation/Permeabilization Buffers . Cells in the lymphocyte gate were used for analysis. Image using the PerCP/Cy5.5 format of this antibody.](http://images.novusbio.com/fullsize/T-bet-TBX21-Antibody-4B10-Flow-Intracellular-NBP1-43298-img0005.jpg)
![Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Western-Blot-NBP2-45868-img0005.jpg "Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.")
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Paraffin-embedded Carcinoma of Human prostate tissue using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-Paraffin-NBP2-45868-img0006.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0001.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0002.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0003.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0004.jpg)
![Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)](http://images.novusbio.com/fullsize/IFIT3-Antibody-OTI1G1-Western-Blot-NBP2-02148-img0010.jpg "Western Blot: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Analysis of extracts (35ug) from 9 different cell lines by using anti-IFIT3 monoclonal antibody at 1:200 dilution. (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human)")
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (OTI1G1) [NBP2-02148] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0009.jpg)
![Flow Cytometry: IFIT3 Antibody (1G1) [NBP2-02148] - Analysis of Jurkat cells, using anti-IFIT3 antibody, (Red) compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Flow-Cytometry-NBP2-02148-img0001.jpg)
![Western Blot: IFIT3 Antibody (1G1) [NBP2-02148] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IFIT3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IFIT3.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Western-Blot-NBP2-02148-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: IFIT3 Antibody (1G1) [NBP2-02148] - Immunofluorescent staining of HT29 cells using anti-IFIT3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IFIT3-Antibody-1G1-Immunocytochemistry-Immunofluorescence-NBP2-02148-img0003.jpg)
![IFIT3 Antibody (OTI1G1)[NBP2-02148]Simple Western� analysis of endogenous protein GBE1 from SH-SY5Y lysates (0.1mg/mL) using GBE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at a 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-02148_mouse-ifit3-mab-oti1g1-simple-western-131120251236354.jpg%253fstore=america&image-type=image)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).")
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in Hela cells (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of Hela cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane and cytoplasm of NIH-3T3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0005.jpg)
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in mouse splenocytes (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0001.jpg)